- Laboratory
- Laboratory medicine
- COVID-19 rapid test
- Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
COVID-19 rapid test IGRA ELISAproteinSARS-COV-2whole blood
Add to favorites
Compare this product
Characteristics
- Applications
- COVID-19
- Tested parameter
- protein
- Micro-organism
- SARS-COV-2
- Sample type
- whole blood
Description
WANTAI SARS-CoV-2 IGRA is an enzyme-linked immunosorbent assay for quantitative detection of Interferon Gamma (IFN-γ) that responds to in-vitro stimulation by spike protein of SARS-CoV-2 in human whole blood. It is intended for use as an aid in the diagnosis of specific T cellular immune response of SARS-CoV-2 spike protein after vaccination or infection.
Catalogs
No catalogs are available for this product.
See all of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. ‘s catalogsOther Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. products
COVID 19
Related Searches
- Blood rapid diagnostic test
- Immunoassay rapid diagnostic test
- Rapid virus test
- Serum rapid diagnostic test
- Plasma rapid diagnostic test
- Whole blood rapid diagnostic test
- Rapid respiratory infection test
- COVID-19 rapid diagnostic test
- Clinical rapid diagnostic test
- Nasopharyngeal rapid diagnostic test
- Rapid oral flu test
- Coronavirus rapid diagnostic test
- Fluorescence rapid diagnostic test
- ELISA rapid diagnostic test
- IgA rapid test
- Sputum rapid diagnostic test
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.